Wednesday 29 September was World Heart Day, and this year’s goal is to harness the power of digital health to improve awareness, prevention and management of CVD globally. At the Alfred Research Alliance, our partners are at the forefront of these efforts by undertaking world-class research and clinical training to drive better outcomes for people affected by heart disease. You can read more about Monash University’s most recent investment in this space below.
Elsewhere on the precinct, Alfred Health has continued their legacy of helping the community with an informative webinar about vaccinating children 12 and up, hosted by the precinct’s own Prof Allen Cheng and paediatrician A/Prof Nigel Crawford from The Royal Children’s Hospital. Some of our partners also look further afield, with Burnet Institute calling for a greater response to managing COVID-19 in the Asia Pacific region and 360biolabs opening a new facility in Brisbane.
Community Vaccination Series Session 1
Here is the first in our series of community information sessions on the COVID-19 vaccines. In this session, Prof Allen Cheng and paediatrician A/Prof Nigel Crawford explain how the COVID-19 vaccine works in children over 12 and answer questions from the community.
Monash University – School of Public Health and Preventive Medicine
World Heart Day
The theme of World Heart Day is How do you #UseHeart and for the Monash Victorian Heart Institute, this speaks to our key purpose to simply deliver research, education and training excellence which turns into measurable change in the rates of heart disease in Australia.
HeartLabs and clinical trials at Victoria’s Health Innovation Centre
Monash University will establish Victoria’s Health Innovation Centre, including a flagship cardiovascular disease-focused research accelerator, HeartLabs, and a new focal point for clinical trials, to create high-value jobs, intellectual property, start-ups, and attract and nurture new clinical trials.
Here’s what happens when you’re hospitalised with COVID
The number of people infected with COVID-19 and requiring treatment in hospital is rapidly increasing. Vaccination provides very effective protection against severe COVID but at current levels of vaccination, outbreaks are still likely to result in large numbers of people requiring treatment in hospital. Thankfully, there are reliable evidence-based guidelines on how to best treat COVID. Here’s what they recommend.
Baker Heart and Diabetes Institute
Fast Five with Dr Guillaume Méric
Dr Guillaume Méric is a microbiologist and bioinformatician, originally from France. After a PhD and postdocs on microbial ecology, evolution and pathogen genomics in the UK, he joined the Cambridge Baker Systems Genomics Initiative in 2018 as a senior research officer.
A regional COVID-19 response needs more from Australia
Chair of Pacific Friends of Global Health and Burnet’s Director and CEO, Professor Brendan Crabb AC calls for greater Australian commitment to COVAX.
360biolabs announces opening of new specialty lab in Brisbane
Continuing to exceed our client’s needs, the opening of our Brisbane laboratory enables 360biolabs to further support clinical trials in the north-east region of Australia.